T. Rowe Price Associates’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.89M | Buy |
36,823
+7,348
| +25% | +$1.77M | ﹤0.01% | 1134 |
|
2025
Q1 | $7.18M | Buy |
29,475
+331
| +1% | +$80.6K | ﹤0.01% | 1177 |
|
2024
Q4 | $9.58M | Buy |
29,144
+1,524
| +6% | +$501K | ﹤0.01% | 1158 |
|
2024
Q3 | $9.24M | Sell |
27,620
-17,730
| -39% | -$5.93M | ﹤0.01% | 1151 |
|
2024
Q2 | $12.4M | Buy |
45,350
+768
| +2% | +$210K | ﹤0.01% | 1070 |
|
2024
Q1 | $15.4M | Buy |
44,582
+748
| +2% | +$259K | ﹤0.01% | 1033 |
|
2023
Q4 | $14.2M | Sell |
43,834
-2,113
| -5% | -$682K | ﹤0.01% | 1030 |
|
2023
Q3 | $16.5M | Sell |
45,947
-5,175
| -10% | -$1.86M | ﹤0.01% | 959 |
|
2023
Q2 | $19.4M | Sell |
51,122
-350
| -0.7% | -$133K | ﹤0.01% | 942 |
|
2023
Q1 | $24.7M | Sell |
51,472
-4,356
| -8% | -$2.09M | ﹤0.01% | 865 |
|
2022
Q4 | $23.5M | Sell |
55,828
-11,450
| -17% | -$4.81M | ﹤0.01% | 865 |
|
2022
Q3 | $28.1M | Buy |
67,278
+339
| +0.5% | +$141K | ﹤0.01% | 805 |
|
2022
Q2 | $33.1M | Sell |
66,939
-3,445
| -5% | -$1.71M | ﹤0.01% | 1010 |
|
2022
Q1 | $39.6M | Sell |
70,384
-3,073
| -4% | -$1.73M | ﹤0.01% | 1050 |
|
2021
Q4 | $55.5M | Sell |
73,457
-749
| -1% | -$566K | 0.01% | 963 |
|
2021
Q3 | $55.4M | Sell |
74,206
-7,785
| -9% | -$5.81M | 0.01% | 971 |
|
2021
Q2 | $52.8M | Buy |
81,991
+9,321
| +13% | +$6.01M | ﹤0.01% | 1006 |
|
2021
Q1 | $41.5M | Buy |
72,670
+36,163
| +99% | +$20.7M | ﹤0.01% | 1065 |
|
2020
Q4 | $21.3M | Sell |
36,507
-56,411
| -61% | -$32.9M | ﹤0.01% | 1213 |
|
2020
Q3 | $47.9M | Sell |
92,918
-19,413
| -17% | -$10M | 0.01% | 886 |
|
2020
Q2 | $50.7M | Sell |
112,331
-43,405
| -28% | -$19.6M | 0.01% | 849 |
|
2020
Q1 | $54.6M | Buy |
155,736
+529
| +0.3% | +$185K | 0.01% | 754 |
|
2019
Q4 | $57.4M | Buy |
155,207
+238
| +0.2% | +$88.1K | 0.01% | 867 |
|
2019
Q3 | $51.6M | Sell |
154,969
-2,172
| -1% | -$723K | 0.01% | 863 |
|
2019
Q2 | $49.1M | Sell |
157,141
-860
| -0.5% | -$269K | 0.01% | 899 |
|
2019
Q1 | $48.3M | Sell |
158,001
-1,886
| -1% | -$577K | 0.01% | 892 |
|
2018
Q4 | $37.1M | Buy |
159,887
+8,983
| +6% | +$2.09M | 0.01% | 934 |
|
2018
Q3 | $47.2M | Buy |
150,904
+6,065
| +4% | +$1.9M | 0.01% | 935 |
|
2018
Q2 | $41.8M | Buy |
144,839
+5,690
| +4% | +$1.64M | 0.01% | 957 |
|
2018
Q1 | $34.8M | Buy |
139,149
+253
| +0.2% | +$63.3K | 0.01% | 998 |
|
2017
Q4 | $33.2M | Buy |
138,896
+1,145
| +0.8% | +$273K | 0.01% | 1016 |
|
2017
Q3 | $30.6M | Buy |
137,751
+8,352
| +6% | +$1.86M | 0.01% | 1031 |
|
2017
Q2 | $29.3M | Sell |
129,399
-1,975
| -2% | -$447K | 0.01% | 1030 |
|
2017
Q1 | $26.2M | Buy |
131,374
+15,235
| +13% | +$3.04M | ﹤0.01% | 1053 |
|
2016
Q4 | $21.2M | Sell |
116,139
-2,898
| -2% | -$528K | ﹤0.01% | 1120 |
|
2016
Q3 | $19.5M | Buy |
119,037
+4,800
| +4% | +$786K | ﹤0.01% | 1139 |
|
2016
Q2 | $16.3M | Sell |
114,237
-1,515
| -1% | -$217K | ﹤0.01% | 1157 |
|
2016
Q1 | $15.8M | Sell |
115,752
-6,080
| -5% | -$831K | ﹤0.01% | 1155 |
|
2015
Q4 | $16.9M | Buy |
121,832
+8,242
| +7% | +$1.14M | ﹤0.01% | 1136 |
|
2015
Q3 | $15.3M | Buy |
113,590
+23,100
| +26% | +$3.1M | ﹤0.01% | 1179 |
|
2015
Q2 | $13.6M | Buy |
90,490
+38,900
| +75% | +$5.86M | ﹤0.01% | 1257 |
|
2015
Q1 | $6.97M | Buy |
51,590
+4,300
| +9% | +$581K | ﹤0.01% | 1418 |
|
2014
Q4 | $5.7M | Sell |
47,290
-3,400
| -7% | -$410K | ﹤0.01% | 1440 |
|
2014
Q3 | $5.75M | Hold |
50,690
| – | – | ﹤0.01% | 1432 |
|
2014
Q2 | $6.07M | Buy |
50,690
+2,400
| +5% | +$287K | ﹤0.01% | 1424 |
|
2014
Q1 | $6.19M | Sell |
48,290
-200
| -0.4% | -$25.6K | ﹤0.01% | 1397 |
|
2013
Q4 | $5.99M | Sell |
48,490
-600
| -1% | -$74.2K | ﹤0.01% | 1403 |
|
2013
Q3 | $5.77M | Sell |
49,090
-600
| -1% | -$70.5K | ﹤0.01% | 1396 |
|
2013
Q2 | $5.58M | Buy |
+49,690
| New | +$5.58M | ﹤0.01% | 1385 |
|